These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23784959)

  • 1. Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma.
    del Campo AB; Kyte JA; Carretero J; Zinchencko S; Méndez R; González-Aseguinolaza G; Ruiz-Cabello F; Aamdal S; Gaudernack G; Garrido F; Aptsiauri N
    Int J Cancer; 2014 Jan; 134(1):102-13. PubMed ID: 23784959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma.
    Paschen A; Arens N; Sucker A; Greulich-Bode KM; Fonsatti E; Gloghini A; Striegel S; Schwinn N; Carbone A; Hildenbrand R; Cerwenka A; Maio M; Schadendorf D
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3297-305. PubMed ID: 16740750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
    Hicklin DJ; Wang Z; Arienti F; Rivoltini L; Parmiani G; Ferrone S
    J Clin Invest; 1998 Jun; 101(12):2720-9. PubMed ID: 9637706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete loss of HLA class I antigen expression on melanoma cells: a result of successive mutational events.
    Paschen A; Méndez RM; Jimenez P; Sucker A; Ruiz-Cabello F; Song M; Garrido F; Schadendorf D
    Int J Cancer; 2003 Mar; 103(6):759-67. PubMed ID: 12516095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes.
    Bernal M; Ruiz-Cabello F; Concha A; Paschen A; Garrido F
    Cancer Immunol Immunother; 2012 Sep; 61(9):1359-71. PubMed ID: 22833104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance.
    Hicklin DJ; Dellaratta DV; Kishore R; Liang B; Kageshita T; Ferrone S
    Melanoma Res; 1997 Aug; 7 Suppl 2():S67-74. PubMed ID: 9578419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric cancer progression may involve a shift in HLA-E profile from an intact heterodimer to β2-microglobulin-free monomer.
    Sasaki T; Ravindranath MH; Terasaki PI; Freitas MC; Kawakita S; Jucaud V
    Int J Cancer; 2014 Apr; 134(7):1558-70. PubMed ID: 24105714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.
    Del Campo AB; Carretero J; Muñoz JA; Zinchenko S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F; Aptsiauri N
    Cancer Gene Ther; 2014 Aug; 21(8):317-32. PubMed ID: 24971583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient recovery of HLA class I expression in human tumor cells after beta2-microglobulin gene transfer using adenoviral vector: implications for cancer immunotherapy.
    del Campo AB; Aptsiauri N; Méndez R; Zinchenko S; Vales A; Paschen A; Ward S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F
    Scand J Immunol; 2009 Aug; 70(2):125-35. PubMed ID: 19630918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
    Chang CC; Campoli M; Restifo NP; Wang X; Ferrone S
    J Immunol; 2005 Feb; 174(3):1462-71. PubMed ID: 15661905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.
    Cabrera T; Lara E; Romero JM; Maleno I; Real LM; Ruiz-Cabello F; Valero P; Camacho FM; Garrido F
    Cancer Immunol Immunother; 2007 May; 56(5):709-17. PubMed ID: 16960691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas.
    Feenstra M; Veltkamp M; van Kuik J; Wiertsema S; Slootweg P; van den Tweel J; de Weger R; Tilanus M
    Tissue Antigens; 1999 Sep; 54(3):235-45. PubMed ID: 10519360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15.
    Garrido MA; Rodriguez T; Zinchenko S; Maleno I; Ruiz-Cabello F; Concha Á; Olea N; Garrido F; Aptsiauri N
    Immunogenetics; 2018 Nov; 70(10):647-659. PubMed ID: 30145665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
    Maleno I; Aptsiauri N; Cabrera T; Gallego A; Paschen A; López-Nevot MA; Garrido F
    Immunogenetics; 2011 Feb; 63(2):65-71. PubMed ID: 21086121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evolution of T-cell resistance in the course of melanoma progression.
    Sucker A; Zhao F; Real B; Heeke C; Bielefeld N; Maβen S; Horn S; Moll I; Maltaner R; Horn PA; Schilling B; Sabbatino F; Lennerz V; Kloor M; Ferrone S; Schadendorf D; Falk CS; Griewank K; Paschen A
    Clin Cancer Res; 2014 Dec; 20(24):6593-604. PubMed ID: 25294904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and genetic basis of MHC, beta-2-microglobulin and MEMO-1 loss of heterozygosity in sporadic breast cancer.
    McEvoy CR; Seshadri R; Morley AA; Firgaira FA
    Tissue Antigens; 2002 Sep; 60(3):235-43. PubMed ID: 12445306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of human leukocyte antigen class I and β2-microglobulin in colorectal cancer and its prognostic impact.
    Na HY; Park Y; Nam SK; Lee KS; Oh HK; Kim DW; Kang SB; Kim WH; Lee HS
    Cancer Sci; 2021 Jan; 112(1):91-100. PubMed ID: 33159376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells.
    Wang Z; Arienti F; Parmiani G; Ferrone S
    Eur J Immunol; 1998 Sep; 28(9):2817-26. PubMed ID: 9754569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of chromosome 15 aneuploidy in head and neck squamous cell carcinoma lesions identified by FISH analysis: limited value of beta2-microglobulin LOH analysis.
    Koene GJ; Arts-Hilkes YH; van der Ven KJ; Rozemuller EH; Slootweg PJ; de Weger RA; Tilanus MG
    Tissue Antigens; 2004 Oct; 64(4):452-61. PubMed ID: 15361122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.